Horizon Texofab Private Limited
About Horizon Texofab Private Limited
Data last updated:
Horizon Texofab Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the textile retail and distribution segment of the home and lifestyle products sector. It was incorporated on 12 May 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U17290DL2010PTC202537.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Sangeeta Grover and Prem Grover.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at S – 292 Ground Floor Greater Kailash – II, New Delhi, Delhi, India – 110048.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.84 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹44,233 (net margin 5.6%) and EBITDA of ₹59,109 (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 27% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Horizon Texofab Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS – 292 Ground Floor Greater Kailash – II, New Delhi, Delhi, India – 110048
- IndustryHome & Lifestyle, Textile Retail & Distribution, Home Furnishings & Accessories Retail
To see the full contact details of Horizon Texofab Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Horizon Texofab is professional, scientific and technical. In detail, this covers advertising and market research.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M6 | Advertising and market research |
To see the full business activity and turnover split of Horizon Texofab Private Limited, buy the company report.
Financials of Horizon Texofab Private Limited
FY 2024 filings availableHorizon Texofab Private Limited reported revenue of ₹7.84 Lakh (up 211% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 211% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59,109 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44,233 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Horizon Texofab Private Limited, buy the company report.
Board of directors of Horizon Texofab Private Limited
Horizon Texofab has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangeeta Grover | Director | 12 May 2010 | 16 Years 5 Months | Current |
| Prem Grover | Director | 01 Sep 2012 | 14 Years 2 Months | Current |
Auditor
Horizon Texofab Private Limited is audited by BALRAM & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BALRAM & ASSOCIATES | FY 2023 | 009579N |
Shareholding
The shareholding of Horizon Texofab Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Horizon Texofab Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Horizon Texofab Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Horizon Texofab Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Horizon Texofab Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Horizon Texofab Private Limited has 6 board changes on record since 2010: 4 appointments and 2 cessations. The latest: Ashok Grover ceased to be Director on 01 Feb 2024.
Frequently asked questions
Horizon Texofab is an active private limited company based in New Delhi, Delhi, India. The company works in textile retail and distribution, within the home and lifestyle industry. It was incorporated on 12 May 2010 (16+ years old) and is registered under CIN U17290DL2010PTC202537.
Horizon Texofab has 2 current directors:
- Sangeeta Grover - Director
- Prem Grover - Director
The latest financial statements of Horizon Texofab on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Horizon Texofab is U17290DL2010PTC202537. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Horizon Texofab was incorporated on 12 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
Ashok Grover ceased to be Director on 01 Feb 2024. Garima Grover ceased to be Director on 21 Jan 2023. Garima Grover was appointed as Director on 14 Sep 2016. Horizon Texofab has 6 board changes on record in total.
The registered office of Horizon Texofab is at S – 292 Ground Floor Greater Kailash – II, New Delhi, Delhi, India – 110048.
Horizon Texofab operates in the home and lifestyle industry, in the textile retail and distribution segment.
The compliance status of Horizon Texofab is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.
Horizon Texofab can be reached at its registered office: S – 292 Ground Floor Greater Kailash – II, New Delhi, Delhi, India – 110048.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
